Skip to main content
. 2017 Apr 8;8(23):37332–37341. doi: 10.18632/oncotarget.16953

Table 1. Characteristics of the 28 patients with transcriptomic analyses of metastatic lymph nodes.

With brain metastases n = 13 Without brain metastases n = 15 p-value
Median age at diagnosis (range) 53 years (38–70) 56 years (26–65) ns
Median survival from diagnosis of metastatic disease (range) 22.7 months(0.5 – 74.1) 34.4 months(14.2–80.3) < 0.01
Histological sub-type: n (%)
 HER2-overexpressed 5 (38.5) 7 (46.5) ns
 Triple negative 8 (61.5) 8 (53.5)